Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01OWB
|
|||
| Former ID |
DIB001073
|
|||
| Drug Name |
Immune globulin
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Approved | [1] | |
| Bone marrow transplantation [ICD-11: QB63.6; ICD-9: 279.5, 996] | Approved | [2] | ||
| Immune System disease [ICD-11: 4A01-4B41; ICD-10: D80-D89] | Approved | [2] | ||
| Immunodeficiency [ICD-11: 4A00-4A85; ICD-9: 279.3] | Approved | [2] | ||
| Virus infection [ICD-11: 1A24-1D9Z] | Approved | [2] | ||
| Nervous system paraneoplastic or autoimmune disorders [ICD-11: 8E4A.1] | Phase 3 | [3] | ||
| Pediatric cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-C96; ICD-9: 140-229] | Phase 2 | [4] | ||
| Bacillus anthracis infection [ICD-11: 1G40] | Phase 1 | [5] | ||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Octapharma. | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | ClinicalTrials.gov (NCT00110708) Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism. U.S. National Institutes of Health. | |||
| REF 5 | ClinicalTrials.gov (NCT00448253) Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.